Aquestive Therapeutics, Inc. (AQST) Operating income 2017–2025
Aquestive Therapeutics, Inc. (AQST) annual operating income history from SEC filings — each fiscal year as reported.
-$71.1MFY2025 · since FY2017: -$113,000 → -$71.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$71.1M | -130.9% |
| FY2024 | -$30.8M | -103.8% |
| FY2023 | -$15.1M | +64.1% |
| FY2022 | -$42.1M | -21.3% |
| FY2021 | -$34.7M | +19.1% |
| FY2020 | -$42.9M | +18.6% |
| FY2019 | -$52.7M | -7.6% |
| FY2018 | -$48.9M | -43204.4% |
| FY2017 | -$113,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice